Geron Corporation (0IV3.L)

USD 1.38

(0.77%)

Eps Summary of Geron Corporation

  • Geron Corporation's latest annual eps in 2023 was -0.32 USD , up 13.51% from previous year.
  • Geron Corporation's latest quarterly eps in 2024 Q1 was -0.09 USD , down -5.03% from previous quarter.
  • Geron Corporation reported an annual eps of -0.37 USD in 2022, down 0.0% from previous year.
  • Geron Corporation reported an annual eps of -0.37 USD in 2021, down -32.14% from previous year.
  • Geron Corporation reported a quarterly eps of -0.09 USD for 2024 Q1, down -5.03% from previous quarter.
  • Geron Corporation reported a quarterly eps of -0.08 USD for 2023 Q3, up 14.02% from previous quarter.

Annual Eps Chart of Geron Corporation (2023 - 1996)

Historical Annual Eps of Geron Corporation (2023 - 1996)

Year Eps Eps Growth
2023 -0.32 USD 13.51%
2022 -0.37 USD 0.0%
2021 -0.37 USD -32.14%
2020 -0.28 USD 15.15%
2019 -0.33 USD -120.0%
2018 -0.15 USD 16.67%
2017 -0.18 USD 5.26%
2016 -0.19 USD -63433.33%
2015 0.00 USD 100.13%
2014 -0.23 USD 23.33%
2013 -0.30 USD 44.44%
2012 -0.54 USD 30.77%
2011 -0.78 USD 31.58%
2010 -1.14 USD -42.5%
2009 -0.80 USD -1.27%
2008 -0.79 USD -61.22%
2007 -0.49 USD -4.26%
2006 -0.47 USD 18.97%
2005 -0.58 USD 67.6%
2004 -1.79 USD -84.54%
2003 -0.97 USD 29.2%
2002 -1.37 USD 27.89%
2001 -1.90 USD 13.64%
2000 -2.20 USD 26.67%
1999 -3.00 USD -219.15%
1998 -0.94 USD -3.3%
1997 -0.91 USD 56.25%
1996 -2.08 USD 0.0%

Peer Eps Comparison of Geron Corporation

Name Eps Eps Difference
uniQure N.V. -6.47 USD 95.054%
Agios Pharmaceuticals, Inc. -6.33 USD 94.945%
Amicus Therapeutics, Inc. -0.51 USD 37.255%
Atara Biotherapeutics, Inc. -65.18 USD 99.509%
bluebird bio, Inc. -1.93 USD 83.42%
Cara Therapeutics, Inc. -2.19 USD 85.388%
Imunon, Inc. -2.16 USD 85.185%
Editas Medicine, Inc. -2.02 USD 84.158%
IQVIA Holdings Inc. 7.39 USD 104.33%
Mettler-Toledo International Inc. 36.10 USD 100.886%
Myriad Genetics, Inc. -1.39 USD 76.978%
Neurocrine Biosciences, Inc. 2.56 USD 112.5%
Supernus Pharmaceuticals, Inc. 0.02 USD 1427.801%
Verastem, Inc. -3.96 USD 91.919%
Walgreens Boots Alliance, Inc. -10.01 USD 96.803%
Waters Corporation 10.87 USD 102.944%
Thermo Fisher Scientific Inc. 15.53 USD 102.061%
Biogen Inc. 8.02 USD 103.99%
Nektar Therapeutics -1.45 USD 77.931%
Perrigo Company plc -0.09 USD -240.788%
Dynavax Technologies Corporation -0.05 USD -545.161%
Illumina, Inc. -7.35 USD 95.646%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 96.896%
Iovance Biotherapeutics, Inc. -1.89 USD 83.069%
Heron Therapeutics, Inc. -0.80 USD 60.0%
Unity Biotechnology, Inc. -2.70 USD 88.148%
BioMarin Pharmaceutical Inc. 0.89 USD 135.955%
Sangamo Therapeutics, Inc. -1.48 USD 78.378%
Evolus, Inc. -1.08 USD 70.37%
Adicet Bio, Inc. -3.31 USD 90.332%
Aclaris Therapeutics, Inc. -1.27 USD 74.803%
Regeneron Pharmaceuticals, Inc. 37.05 USD 100.864%
Esperion Therapeutics, Inc. -2.03 USD 84.236%
FibroGen, Inc. -2.92 USD 89.041%
Agilent Technologies, Inc. 4.22 USD 107.583%
OPKO Health, Inc. -0.25 USD -28.0%
Homology Medicines, Inc. -7.41 USD 95.682%
Alnylam Pharmaceuticals, Inc. -3.52 USD 90.909%
Exelixis, Inc. 0.65 USD 149.231%
Viking Therapeutics, Inc. -0.91 USD 64.835%
Anavex Life Sciences Corp. -0.60 USD 46.667%
Intellia Therapeutics, Inc. -5.42 USD 94.096%
Zoetis Inc. 5.08 USD 106.299%
Axsome Therapeutics, Inc. -5.27 USD 93.928%
Abeona Therapeutics Inc. -2.53 USD 87.352%
Vertex Pharmaceuticals Incorporated 14.05 USD 102.278%
Kala Pharmaceuticals, Inc. -17.35 USD 98.156%
Ionis Pharmaceuticals, Inc. -2.56 USD 87.5%
Sarepta Therapeutics, Inc. -5.80 USD 94.483%
Corcept Therapeutics Incorporated 1.02 USD 131.373%
Halozyme Therapeutics, Inc. 2.13 USD 115.023%
Blueprint Medicines Corporation -8.37 USD 96.177%
Insmed Incorporated -5.34 USD 94.007%
TG Therapeutics, Inc. 0.09 USD 458.343%
Incyte Corporation 2.67 USD 111.985%
Emergent BioSolutions Inc. -14.85 USD 97.845%